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Summary: The time-dependent concentrations of hyaluronan, aminoterminal propeptide of type III procol-
lagen, and laminin were determined in sera of 16 patients with severe adult respiratory distress syndrome
during treatment with an extracorporeal CO2 removal device. Patients were classified according to lung
Parameters äs responders (n = 10) and non-responders (n = 6) to extracorporeal CO2 removal. At the
beginning of treatment strongly elevated serum concentrations of all studied extracellular matrix components
were found. During the first 6—11 days of treatment the concentrations of aminoterminal propeptide of type
III procollagen and hyaluronan increased further in non-responders but decreased in the majority of re-
sponders, while laminin decreased in both groups. No significant correlations were found between the serum
concentrations of connective tissue components and the parameters of lung function. By non-parametric
analysis of variance, significant differences between responders and non-responders according to treatment
time could be established. By analysing the time course of the serum concentrations of hyaluronan and
aminoterminal propeptide of type III procollagen, a total differentiation between responders and non-
responders was made pössible by the trends of these analytes äs early äs three days after the Start of treatment.
The determination of aminoterminal propeptide of type III procollagen and hyaluronan in serum of patients
with adult respiratory distress syndrome might therefore have prognostic significance in extracorporeal CO2
removal.
unfavourable rapid development of pulmonary fibro-
The adult respiratory distress syndrome is a severe sis within about 2 weeks (5, 6), characterized by an
condition of life-threatening organ failure, character- increase in fibroblast numbers and accelerated colla-
ized by tachypnoea, hypoxaemia, diffuse interstitial gen metabolism (7, 8).
mfiltrates, alveolar oedema, and loss of lung compli-
ance (l, 2). The syndrome develops in response to a Components of the extracellular matrix have been
primary attack on lung cells like inhalation of toxins, determined in blood of patients with fibrotic lung
aspiration of gastric contents (3) or äs a consequence diseases, but in contrast to e. g. liver fibrosis there
of systemicdisorders like septicshock and multiorgan seems to be only a weak association between the
trauma. Severe, progressive cases are associated with concentrations of such analytes in blood and the
a mortality rate of up to 90% (4). One sequel of adult activity and/or grade of the fibrosing process in the
respiratory distress syndrome is the prognostically lung (9).
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More promising results were obtained with measure-
ments of extracellular matrix components in bron-
choalveolar fluid from patients with interstitial lung
diseases, e. g. sarcoidosis or farmer's lung. High con-
centrations of hyaluronan (hyaluronic acid), a gly-
cosaminoglycan polymer and main constituent of
loose connective tissue (10) and of the aminoterminal
propeptide of type III procollagen (l 1), a split product
originating from the synthesis and maturation of type
III collagen, have been found in the lavage fluid (12,
13) and were proposed äs indicators for assessing
disease severity and outcome. Recently, Hällgren et
al. (14) have reported elevated concentrations of hy-
aluronan in bronchoalveolar lavage fluid from pa-
tients with adult respiratory distress syndrome. They
further found strongly increased concentrations of
hyaluronan and aminoterminal propeptide of type III
procollagen in the serum of these patients. We have
made similar observations with regard to aminoter-
minal propeptide of type III procollagen and laminin
in a preliminary study (l 5). As an alternative to con-
ventional refcpiratory treatment of adult respiratory
distress syndrome, the recently established concept of
extracorporeal CO2 removal by membrane-lungs in
conjunction with apneic oxygenation (16—19) has
been introduced. In the present work we have inves-
tigated the time course of the serum levels of hyalu-
ronan, aminoterminal propeptide of type III procol-
lagen, and laminin, a high molecular mass glycopro-
tein and main constituent of basement membranes
(20), in sera of patients with severe adult respiratory
distress syndrome treated with extracorporeal CO2
removal.
Materials and Methods
Patients
Sixteen adult respiratory distress syndrome patients, mean age
29 (ränge 6—59) years, 10 females, were included in the study.
All patients were admitted to the intensive care unit of the
departraent of anaesthesia of our hospital within a total period
of 1.5 years because of severe pulmonary failure and treated
here with the method of extracorporöäl CÖ2 removal. The mean
duration of conventional respiratory treatment before extra-
corporeal CO2 removal was 15 ± 8 (mean ± SD) days. The
mean duration of extracorporeal CO2 removal treatment was
11+6 days. Only patients with stage 4 (final stage) pf the
disease according to the classification scheme of Morel (21)
were included. The following criteria had to be fulfilled for
inclusion:
(i) demonstration of typical interstitial and alveolar Infiltrates
by X-ray and less than 20% of normal aerated lung regions
by Computer tomography,
(ii) mean pulmonary artery pressure of at least 35 mmHg,
(iii) alveolo-arterial oxygen pressure difference under 100%
oxygen in excess of 525 mmHg, and
(iv) total compliance of the respiratory System less than 30 ml/
cm H2O.
The initiating events of adult respiratory distress syndrome and
other pertinent Information abput our patients are given in
table 1. Patients weire classified äs responders (n = 10, patients
whose condition could be improved by extracorporeal CO2
removal to such an extent that they could be weaned from the
respirator) and non-resppnders (n = 6, non-survivors) to ex-
tracorporeal CO2 removal äs assessed by extravasculaf lung
water volume, lung compliance and alveolo-iarterial oxygen
pressure difference. Two of the responders died, however, äs a
consequence of their primary injury (cases 2 and 4 in tab. 1).
All patients received a continuous heparin applicätiön of 800—
2500 U/h during the extracorporeal CO2 elimination.
Extracorporeal CO2 removal
The methodology pf extracorporeal CÖ2 removai is described
in detail elsewhere (22-24).
Tab. l. Summary of patient Information.
NS: non-survivor, S: survivor, NR: non-responder, R: responder
Patient
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Age
26
6
27
56
20
30
34
37
55
46
59
11
44
42
16
45
Gender
9
9
<f?9
9
<J
9
?
<?
?
9
9
S
c?
Underlying
disease
Aspiration
Polytrauma
Polytrauma
Pneumonia
Polytrauma
Aspiration
Polytrauma
Polytrauma
Postoperative
Pneumonia
Postoperative
Pneumonia
Peritonitis
Postoperative
Polytrauma
Aspiration
Course
NS
NS
NS
NS
NS
S
S
S
S
S
NS
S
NS
S
S
NS
Class
NR
R
NR
R
NR
R
R
R
R
R
NR
R
NR
R
R
NR
Duration of arti-
ficial Ventilation
before extracorporeal
CO2 removal
19
11
9
11
16
10
24
10
11
15
8
28
38
20
9
10
Duration of extra-
corporeal CO2
removal treatment
12
22
5
5
1
10
9
6
20
21
8
3
12
14
15
13
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Quanti l ies of pulmonary function and haemo-
dynamics
On each day of extracorporeal CO2 removal treatment the
pulmonary function was assessed by a sei of repräsentative
Parameters. The intrapulmonal right-left shunt (Qs/Qr), al-
veolo-arterial oxygen pressure difference, mean pulmonary ar-
terial pressure, and cardiac outpul were determined by Standard
techniques. Extravascular lung water was measured according
to a double indicator method (25).
the relatively small number of cases on single days, the time-
dependent quantities were computed by combining values ob-
tained on single days into three groups: days 0—2, days 3—7,
and day 8 and following. This stratification was chosen to cover
the early, medium and late stages of the treatment process. The
rcsults of the statistical analysis were insensitive to small
changes (± l day) of the temporal groupings.
All statistical computations were performed using the SAS PC
V 6.03 statistical package (SAS Institute, Cary, NC).
Specimen collection
Biood samples were collected immediately before and through-
out the extracorporeal CO2 removal treatment once a day.
Blood was drawn from the inlet line of the membrane lungs,
cooled on ice, clotted at room tcmperature for at least 60
minutes, and centrifuged. The serum was stored in aliquots at
-70 °C until analysis, which was performed within onc run for
all analytes. We found no significant difference in the concen-
trations of extracellular matrix components belween samples
drawn at the rnembrane inlet line and after passage through
the membrane lungs, or between samples drawn immediately
before and after renewal of the membrancs. While this does
not exclude small long-term adsorption effects at the mem-
branes, such effects, if they exist, should not bias our results
and their Interpretation because they will operate equally on
all measurements.
Analytical methods
Laminin was measured in serum using a competitive RIA
(Hoechst AG, Frankfurt, F. R. G.) with antibodies directed
against antigenic determinants of fragment P l (26). The ana-
lytical details have been described before (27). The within-run
and day-to-day imprecisions were 3.1 and 4.9%, respectively
(x = 1.8 kU/1). The concentrations of laminin in serum are
given in arbitrary units based on the medium value of the serum
concentrations in a healthy control population (26).
Hyaluronan was detennined by a previously described radio-
metric assay (Pharmacia, Uppsala, Sweden) (28). The intra-
and inter-assay coefiicients of Variation (CV) (x = 182 g/l)
were 6.9% and 7.3%, respectively.
The aminoterminal propeptide of type III procollagen was
measured in various dilutions of serum using a radioimmu-
noassay (Behringwerke^ Marburg, F. R. G.) based on intact
polyclonal antibodies recognizing mainly the higher molecular
mass (intact) propeptide Col 1-3 (29, 30). The within-run CV
was 4.9% (x = 12 /*g/l; n = 14), the day-to-day CV was 7.2%
(i = 5.0 jig/1; = 12).
Additional clinical chemical parameters, including alanine ami-
notransferase, creatinine, and haematocrit were determined ac-
cording to Standard methods (31).
Data analysis
For descriptive statistical analysis the daity mean concentra-
tipns of the respective analytes were computed separately
for the survivor/non-survivor and responder/non-responder
groups, respectively.
The association between parameters was tested using Spear-
/wa/i's rank correlation coefficients (32). For testing diflerences
between groups, the values of all numerical variables were first
converted into ranks. These ranks, taken separately within each
group, were subsequently used äs input for an analysis of
variance (ANOVA) procedure. By using ranks instead of the
original values of a variable the ANOVA becpmes equivalent
to a non-parametric method,'Le. Kruskal-Wallis. Because of
Results
Time course of the serum concentrations of
connective tissue components
The individual, time-dependent changes of the serum
concentrations of aminoterminal propeptide of type
III procollagen, laminin, and hyaluronan within the
first 5 — 11 days after onset of the extracorporeal CO2
removal treatment (day 0) are depicted in figure 1.
The values of one patient who died within one day
and of another patient whose treatment was stopped
at day 3 were omitted from the figure. The initial
serum concentrations of the connective tissue com-
ponents were clearly above the reference limit in most
patients. This was most pronounced for aminoter-
minal propeptide of type III procollagen (reference
ränge: 2—12 g/l (11)) and laminin (reference ränge:
1.08-1.90 kU/1 (33)) and was seen in fewer cases for
hyaluronan (reference ränge: 10—100 g/l (34)). The
patterns of values in responders who died did not
differ distinctly from those of surviving responders.
During the course of the treatment the laminin con-
centrations generally strongly decreased in both the
responder and the non-responder group. The decrease
was more pronounced in the responder than in the
non-responder group (fig. 1). In one non-responder a
slight increase in the concentration was observed. (For
technical and organizational reasons laminin could
not be determined in 4 patients).
The initial aminoterminal propeptide of type III pro-
collagen concentrations in the responder group de-
creased with one exception. However, all values were
still above the upper reference limit after 10 days. In
the non-responder group, with one exception, the
serum concentrations increased further after day 0 of
extracorporeal CO2 removal treatment.
Two of the responders and two of the non-responders
to the extracorporeal CO2 removal treatment had
normal serum concentrations of hyaluronan at day 0,
but clearly different trends with time of treatment
were observed for this quantity in the two groups. In
responders the serum levels declined or remained con-
stant, while in the non-responder group all patients
showed strongly incresing concentrations of serum
hyaluronan.
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Fig. l. Individual trends in the concentrations of the extracellular matrix components laminin (a), aminoterminal propeptide pf
type III procollagen (b), and hyaluronan (c) in serum of adult respiratory distress syndrome patients after Start of
extracorporeal CO2 removal treatment. Values of non-surviving resporiders are shown s dotted lines.
The discrimination between responders and non-re-
sponders on the basis of connective tissue components
in serum is expressed more clearly by the trends of
the parameters than by their absolute values. To dem-
onstrate these trends, figures 2 and 3 show for hyalu-
ronan and aminoterminal propeptide of type III pro-
collagen all changes relative to the initial values on
day 0 for each patient. From these presentations it
becornes obvious that within three days after Start of
the treatment all non-responders are fully separated
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Fig. 2. Relative changes (concentration at time t — concentra-
tion at time 0 / concentration at time r) of individual
serum concentrations of hyaluronan in non-responders
(solid lines) s compared to their concentration at Start
of extracorporeal CO2 removal treatment in comparison
to the concentration r nge (shaded area) found for
responders.
-1.5
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Fig. 3. Relative changes (concentration at time t — concentra-
tion of time 0 / concentr tion at time t) of individual
serum concentrations of aminotenninal propeptide of
type III procollagen in non-responders (solid lines) s
cpmpared to their concentration at Start of extracor-
poreal CO2 removal treatment in comparison of the
concentration r nge (shaded area) found for responders.
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from the responders by their increasing concentra-
tions of serum hyaluronan and aminoterminal pro-
peptide of type III procollagen.
Statistical analysis
No conspicuous correlations emerged between the
concentrations of extracellular matrix components in
serum and the physical quantities of lung function
within individual patients. This lack of significance is
partly caused by the small number of values for each
patient and by the different trends of the physical and
chemical parameters with time. For example alveolo-
arterial oxygen pressure difference (fig. 4) decreased,
äs expected, in responders but remained high in non-
responders, whereas the concentrations of the extra-
cellular matrix components generally increased in
non-responders during the course of the disease.
For testing differences between groups the original
values of the variables were transformed into ranks
äs described under Data analysis. In the ANOVA
procedure, 'time' (levels: days 0—2, days 3—7, and
days 8 and following after Start of extracorporeal CO2
removal) and 'response' (levels: responder and non-
700
100
2 4 6 8 10
Time of treatment [dl
Fig. 4. Ittdividual trends in the alveolo-arterial oxygen differ-
ence of adult respiratory distress syndrome patients
after Start of extracorporeal CO2 removal treatment.
Values of non-surviving responders are shown äs dotted
lines.
Tab. 2. ANOVA results for the extracelhilar matrix compo-
nents, some Standard clinical chemical analytes and
quantities of lung function.
(*: P < 0.05, **·
significant)
p < 0.01, ***: p < 0.001, NS not
Parameter
Hyaluronan
Laminin
Aminoterminal propeptide
of type III procollagen
Alveolo-arterial oxygen
pressure difierence
Extravascular lung water
Shunt fraction
Creatinine
Alanine aminotransferase
Haematocrit
Effects
Time
NS
**
NS
NS
NS
NS
*
NS
NS
Re-
sponse
**
**
**
***
NS
***
***
NS
***
Time Response
*
*
*
NS
NS
NS
NS
NS
NS
responder) were used äs main effects (tab. 2). Addi-
tionally, a second order combined effect of time-
response was tested. With laminin, and to a lesser
extent with creatinine, significantly different levels
with regard to time were found, which can be ex-
plained (see fig. 1) by the fact that all patients showed
decreasing serum laminin concentrations with time,
whereas for the other quantities both decreasing and
increasing values were found due to the classification
of the patients in the responder and non-responder
group, respectively. Significant differences between
responders and non-responders were found in the
serum concentrations of extracellular matrix compo-
nents, serum creatinine, haematocrit, and in the al-
veolo-arterial oxygen pressure difference and shunt
fraction. The high significances found for alveolo-
arterial oxygen pressure difference and the shunt frac-
tion are not surprising (and should not be considered
äs an independent effect) because these quantities
were used äs primary criteria for the establishment of
the classification scheine. All three extracellular ma-
trix components, but none of all other investigated
quantities, were significantly different with regard to
the second-order time-response effect. The ANOVA
results obtained with rank data are further supported
by the mean values of the different groups äs shown
in table 3.
Discussion
By serial determination of the serum concentrations
of aminoterminal propeptide of type III procollagen
and hyaluronan in adult respiratory distress syndrome
patients undergoing extracorporeal CO2 removal
treatment a prognostic evaluation of potential re-
sponders and non-responders can be reached äs early
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 29,1991 / No. 12
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Tab. 3. Mcan scruni conccnlrations of conncctive tissue components, of some Standard clinical chemical analytes and of lung
function quantities according to time after onset of extracorporeal CO2 removal treatment in responders (R) and non-
responders (NR). The Standard error of means is given in parenthesis below the vahies.
Parameter
Laminin
Aminoterminal propeptide of type III procollagen
Hyaluronan
Creatinine
Alanine aminotransferase
Haematocrit
Alveolo-arterial oxygen pressure difference
Extravascular lung water
Shunt fraction
. .
Unils
kU/1
μ§/ι
μΕ/1
μιηοΐ/l
U/l
l/l
mmHg
1
%
Day 0-2
R
2.77
(0.16)
85
(10)
272
(68)
80
(6)
25
(5)
0.39
(0.005)
457
(20)
1.19
(0-12)
34.6
(15)
NR
2.72
(0.28)
92
(24)
180
(41)
107
(H)
56
(25)
0.41
(0.013)
548
(13)
1.38
(0.23)
43.4
(2.6)
Day 3-7
R
1.75
(0.11)
45
(5)
181
(41)
67
(3)
24
(2)
0.39
(0.005)
314
(26)
0.98
(0.08)
23.4
(2.Q)
NR
2.35
(0.25)93
(9)
368
(68)
146
(20)
34
(13)
0.40
(0.006)
556
(12)
1.29
(0.09)
51.3
(3)
Day > 7
R
1.69
(0.05)
56
(7)
205
(43)
52
(3)
31
(4)
0.38
(0.005)
312
(25)
0.73
(0.10)
23.3
(2.1)
NR
2.19
(0.17)
130
(41)
930
(311)
95
(12)
46
(14)
0.40
(0.011)
554
(9)
0.84
(0.04)
44.1
(3.5)
as three days after onset of therapy. After Start of the
treatment all non-responders could be identified by
their increasing serum concentrations of aminoter-
minal propeptide of type III procollagen and hyalu-
ronan, whereas generally decreasing concentrations of
these analytes were found in responders (figs. 2, 3).
In contrast to other respiratory diseases (9) strongly
elevated concentrations of connective tissue compo-
nents were noticed in sera of adult respiratory distress
syndrome patients. This is in agreement with our
previous observation (15) and with that of H llgren
et al. (14), who assessed patients early in the course
of developing adult respiratory distress syndrome.
Our study was focussed, however, on those patients
with late stages of severe adult respiratory distress
syndrome (cf. tab. l, duration of artificial Ventilation
before extracorporeal CO2 removal) subjected to ex-
tracorporeal CO2 removal treatment (19). With regard
to the statistical analysis, the serum concentrations of
matrix components were the only quantities affected
simultaneously by the effects response and time. This
unique behaviour can be interpreted as the statistical
confirmation of the trends vis alized in figure l.
Presently no clear explanation of the pathobiochem-
ical basis of the significant changes in the concentra^
tions of extracellular matrix components in serum
t during extracorporeal CO2 removal can be given. One
has to keep in mind that the serum levels of the matrix
components are determined not only by the rate of
production in tissues but also by secretion into the
circulation, distribution and clearance (35). Amino-
terminal propeptide of type III procollagen (36), hy-
aluronan (37) and laminin (38) are degraded in the
liver by endothelial cells. Hyaluronan and smaller
fragments of aminoterminal propeptide of type ΙΙΪ
procollagen are extracted by the kidneys (39). Theo-
retically all these pathways might cpntribute to the
elevated levels observed here. We have no indication,
however, that the distribution volume and the clear-
ance rate are changed in our patients, as seen from
the normal or only slightly elevated levels of alanine
aminotransferase, creatinine and haematocrit (tab. 3).
Several experimental studies provide a solid basis for
the assumption of enhanced production of hyalu-
ronan and collagens in damaged lungs due to mac-
rophage-driven fibroblast activation (40—45). An in-
creased outflow into the alveolar space and into the
lymph and blood circulation might explain the find-
ings with respect to bronchoalve lar lavage as well as
our observations with regard to the serum levels. It
has been proposed that artificial Ventilation might
induce a mobilization of hyaluronan from the inter-
stitial space by increasing the microvascular pressure
(14). At least for the late stages of adult respiratory
distress syndrome this hypothesis is not supported by
our data: Although the lungs are resting during ex-
tracorporeal CO2 removal and there is only low fre-
q ency positive pressure Ventilation (which may not
necessarily increase the transm ral Hiicrovascular
pressure), strongly increasing serum concentrations of
hyaluronan were found in most non-responders. Only
for laminin, which shows decreasing serum levels in
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all patieiits, are our data consistent with a contribu-
tion from artificial Ventilation, which in the case might
have influenced an increased turnover of alveolar
basement membranes.
From animal experimental studies it was concluded
that the volume of extravascular hing water is related
to the amount of interstitial hyaluronan (46, 47). It
has been hypothesized that the excessive accumulation
of hyaluronan in the alveolar interstitial space makes
a major contribution to interstitial oedema, due to its
ability to immobilize water. If one assumes that the
serum concentration of hyaluronan is related to its
content in lung tissue, a significant correlation be-
tween hyaluronan and the extravascular lung water
volume might be expected. Since we did not find
consistent significant correlations in the majority of
our patients the data do not support this hypothesis.
A principal difficulty in the Interpretation of the re-
sults lies in the fact that adult respiratory distress
syndrome in many cases is accompanied by severe
primary injuries of various aetiologies. It seems im-
possible to differentiate fully between those effects
specific for adult respiratory distress syndrome and
those related to the polytraumatic lesions which led
to the development of adult respiratory distress syn-
drome. Some arguments can be stated, however, for
the existence of a more or less direct relation between
adult respiratory distress syndrome and the connec-
tive tissue components in serum:
• Our patients were in late stages of severe adult
respiratory distress syndrome with a mean pretreat-
, ment time of 15 ± 8 days at the Start of extracor-
poreal CO2 removal. The underlying disease had
thus in most cases already been overcome.
o From figure l it can be seen that the serum con-
centrations of the connective tissue parameters of
non-surviving responders are not distinct from
those of the surviving responders.
Measurements of extracellular matrix components in
serum present a clearly different approach to the
assessment of severe adult respiratory distress syn-
drome, which otherwise depends on the measurement
of respiratory function. Our results show that the
successful outcome of extracorporeal CO2 elimination
in patients with adult respiratory distress syndrome
is closely and early reflected by the time course of the
serum concentrations of extracellular matrix compo-
nents, aminoterminal propeptide of type III procol-
lagen and hyaluronan, which suggests that these
quantities might gain prognostic significance for ex-
tracorporeal CO2 removal treatment in addition to
gas exchange. Conceivably these non-invasive exam-
inations might prove helpful in monitoring patients
subjected to conventional therapy and in selecting
different therapeutic options, including extracorpo-
real CO2 removal.
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